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Abstract
Here we describe a general synthetic platform for side-chain macrocyclization of an unprotected
peptide library based on the SNAr reaction between cysteine thiolates and a new generation of
highly reactive perfluoroaromatic small molecule linkers. This strategy enabled us to
simultaneously “scan” two cysteine residues positioned from i, i+1 to i, i+14 sites in a
polypeptide, producing 98 macrocyclic products from reactions of 14 peptides with 7 linkers. A
complementary reverse strategy was developed; cysteine residues within the polypeptide were first
modified with non-bridging perfluoroaryl moieties and then commercially available dithiol linkers
were used for macrocyclization. The highly convergent, site-independent, and modular nature of
these two strategies coupled with the unique chemoselectivity of a SNAr transformation allows for
the rapid diversity-oriented synthesis of hybrid macrocyclic peptide libraries with varied chemical
and structural complexities.
Introduction
Cyclic polypeptides represent a unique class of naturally occurring biomolecules often with
enhanced biological properties compared to their linear counterparts.1 These bioactive
macromolecules can be found in a number of bacteria, plants, and mammals.2 Chemists
have aimed to synthesize hybrid macrocyclic polypeptides that mimic the structure and
function of naturally produced bioactives.3 Side-chain to side-chain macrocyclization has
emerged as one method to access such species. This approach entails the cross-linking
between two or more side-chain functional groups with natural or non-natural amino acid
residues. Several methods exist, including nucleophilic substitution with benzyl/allyl halide
electrophiles,4 a myriad of carbon-carbon5 and carbon-nitrogen6 bond-forming processes,
cycloadditions,7 disulfide formation,8 metal-based coordination9 and non-covalent routes.10
Each approach may have drawbacks associated with chemoselectivity, tunability, and
synthetic practicality. Most importantly, regions within a polypeptide are often found to
undergo inefficient macrocyclization with certain chemical approaches. These limitations
reduce the ability to synthesize analogues for potential therapeutic applications.11
An ideal side-chain to side-chain macrocyclization chemistry should possess orthogonality,
specificity, and robustness that allows for cyclization irrespective of the sequence and
position. This can be conceptualized as a scanning approach,12 where one can deliberately
vary the positions of two amino acids as well as the chemical and topological composition of
the entity connecting these two residues (Figure 1). To develop a versatile peptide
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macrocyclization scan, we believe synthetic convergence and site-independent reactivity are
required. Specifically, a convergent diversity-oriented synthetic (DOS) strategy would
enable such a scan, where, in principle, any linear polypeptide can be cyclized as a last,
high-yielding synthetic step with an exogenously added linker.13 The site-independent
reactivity requirement imposes robustness and efficiency for the desired transformation
irrespective of the chemical nature of the polypeptide chain and mutual arrangement of the
residues undergoing macrocyclization. The added complexity and requirements for a
polypeptide macrocyclization scan makes it significantly more challenging and ultimately
requires new approaches. Importantly, none of the existing methods for hybrid peptide
macrocyclization (vide supra) were shown to be fully suitable for the envisioned
macrocyclization scan, including widely-used CLIPS and stapling technologies, developed
by Timmerman et al.4a,d and Verdine et al.,5b–d,f respectively.
The advent and development of “click” chemistry provides researchers with a potentially
powerful series of transformations allowing for selective functionalization of
biomolecules.14 We and others have recently become interested in a formerly unrecognized
reaction between thiol nucleophiles and activated perfluoroaromatic molecules.15 This
reaction satisfies several important prerequisites of being a “click” transformation (Figure
2a).14,15 Our recent study showed one can use two commercially available
perfluoroaromatic reagents (Figure 2b, La and Lb) to cross-link two cysteine moieties
positioned in the i, i+4 fashion within a polypeptide.
This modification improved cell-uptake, proteolytic stability, and target binding of the
corresponding peptide. Cysteine perfluoroarylation was found to be compatible with
unprotected peptides showing excellent chemo- and regioselectivity in the presence of other
reactive functional groups. However, the generality of the perfluoroaryl-cysteine SNAr
chemistry in context of the desired macrocyclization scan has thus far remained challenging.
Herein, we report how a new generation of rationally designed perfluoroaryl-based cross-
linking molecules enables a peptide macrocyclization scan based on the cysteine
perfluoroarylation via the SNAr transformation. Two simple, complementary synthetic
strategies embody the versatility of our approach (Figure 2d). Specifically, access to peptide
macrocycles can be achieved by either cross-linking cysteine containing peptides with
perfluoroaryl-based linkers, or by incorporating non-crosslinked perfluoroaryl-based
moieties first, followed by their macrocyclization with dithiol reagents. The developed
macrocyclization scan is enabled by our strategy to maximize the reactivity of perfluoroaryl-
based synthons without compromising their synthetic accessibility, robustness and
tailorability (Figure 2b,c). Site-independent reactivity of the described platform ultimately
allowed us to conduct highly efficient macrocyclizations in a series of peptides featuring two
cysteine residues incorporated at the positions ranging from i, i+1 to i, i+14 (Figure 2e). The
developed approach is fully convergent allowing for rapid and operationally simple
generation of chemical complexity from unprotected peptides containing naturally occurring
amino-acid residues.
Results and Discussion
In an effort to expand peptide stapling with two Cys moieties beyond i, i+4 positions, we
sought to develop an extended library of bifunctional cross-linking molecules with rationally
varied properties containing two perfluoroaryl units. Based on our experimental
observations, species containing aliphatic groups in the para position exhibited diminished
reactivity toward the nucleophilic attack rendering the SNAr process slow and inefficient
(Figure 2b). This phenomenon is attributed to the poor electron-withdrawing nature of alkyl-
based substituents, which are not sufficiently activating for the para-C-F bond substitution
Zou et al. Page 2
Org Biomol Chem. Author manuscript; available in PMC 2015 January 28.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
at room temperature.17 We thus decided to explore a less-developed activation pathway that
features a para-substituted thioether group appended on perfluoroaryl-based unit.
Specifically, Pitts and co-workers previously observed enhanced reactivity of these reagents
and attributed the effect to net stabilization of the Meisenheimer complex through resonance
stabilization of the negative charge at the para-sulfur on the thioether moiety (Figure 2b).
Our DFT computational studies corroborate the presence of a para-S substituent on the
pentafluorophenyl moiety consistently renders a larger para-C-F bond polarization than in
the alkyl-based substituent-containing congeners (see SI, Table S1). The presence of the
same para-thioether moiety on the biaryl variant does not significantly change para-C-F
dipole features as compared to Lb, though it remains large due to the inductive electron-
withdrawing effect produced by the para-S-C6F4 substituent. Therefore, we chose to focus
our efforts on both S-substituted 1-nonafluorobiphenyl and 1-pentafluorobenzene groups for
facile nucleophilic aromatic substitution chemistry necessary for the bioconjugation (vide
supra).
We utilized two independent routes to synthesize a new class of bifunctional
perfluoroaromatic-based linkers Lc-Lg (note that, linker Lc can also be obtained from an
existing commercial source). Linkers containing alkyl and benzyl moieties were synthesized
via SNAr chemistry between an excess (>25 fold) of commercially available
hexafluorobenzene and alkyl/benzyl dithiol species (see SI for full synthetic procedures).
Utilizing an excess of the perfluoroaromatic reagents ensures the formation of the mono-
substituted species and minimizes the production of oligomeric and polymeric products.18
However, no desired product was observed when these conditions were applied to aromatic
dithiols. To circumvent this, linkers containing aromatic moieties were synthesized via Cu-
mediated cross-coupling of the corresponding aryl halide or dihalide and commercially
available pentafluorophenylthiol (see SI).19 The proposed structural formulations of linkers
Lc-Lg are fully consistent with their heteronuclear NMR spectra in solution (see SI).
To probe peptide macrocyclization with the perfluoroaryl-based linkers, we designed a
series of 14 peptides featuring a diverse set of natural amino-acid residues and two cysteine
moieties deliberately varied at sites from i, i+1 to i, i+14 (labeled as 1–14, see Figure 2e).
To start, we tested the macrocyclization protocol with linkers La and Lb utilizing strategy I
(Figure 2d), wherein bifunctional cross-linkers are expected to interconnect two cysteine
sites producing peptide-based macrocyclic structures. Upon treating 7 with two equivalents
of La in the presence of TRIS base (50 mM, in DMF), we observed nearly complete
consumption of the starting material within 2 hours as determined by LC-MS analysis.
Under these conditions nearly 80% of the macrocycle product 7a was observed in addition
to a small amount of oxidized 7 formed via intramolecular disulfide formation (Figure 3).
When the longer linker Lb was used under the same conditions, the macrocyclic product 7b
formed in >90% yield after 2 hours with a minimal amount of the oxidized by-product. This
noticeable increase in the product yield can be attributed to a longer length and higher
reactivity of Lb as compared to La, rendering the process more efficient. 19F NMR spectra
of the purified peptides 7a–7b are consistent with the proposed cysteine arylation, where
only resonances observed correspond to the 1,4- and 1,10-substituted patterns on the
perfluoroaromatic moieties.20 Given the high sensitivity of 19F nucleus to the local magnetic
field, we observed additional complexity in both of these spectra due to the presence of
slowly exchanging conformers (see SI). The observed dynamic behavior is likely a result of
the slow rotation of the perfluoroaromatic ring moieties, which can be modulated by
temperature and solvent (see SI for variable temperature (VT) NMR spectroscopy studies).
When peptide 7 was treated with the next-generation linkers Lc-Lg, reaction yields were
greater than 85% and not dependent on the chemical nature or length of the moiety. We
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observed small amounts, less than 10%, of cross-linked by-products resulting from the
competing intermolecular processes (Figure 3). Regio- and chemo-selectivity of these
processes were confirmed via 19F NMR spectroscopy of the purified peptides 7c–7d.
Overall, macrocyclization studies with i, i+7 peptide 7 indicates that macrocyclization via
SNAr chemistry between cysteine thiolates and activated perfluoroaromatic linkers La-Lg is
highly efficient and chemoselective (Figure 3). Importantly, in contrast to the stapling
chemistry via olefin metathesis,5a–e this approach does not necessitate the use of non-natural
olefin-containing amino acids as well as precise tuning of the length and stereochemistry of
these residues.
Given recent studies demonstrating the feasibility of peptide macrocyclization with hybrid
linkers at positions beyond those located on the same face of the α-helical loop (single turn
– i, i+4; double turn – i, i+7; triple turn – i, i+11),4a,6a,7a we sought to further test the
developed chemistry by scanning the polypeptide in either direction via this platform.
Conducting macrocyclization reactions with conditions employed for peptide 7, we tested
the corresponding peptides where cysteine residues are positioned in i, i + 6 (peptide 6) and
i, i + 8 (peptide 8) fashion. We observed greater than 75% macrocyclization yields for all 14
reactions with linkers La-Lg, where more flexible linkers produced the corresponding
macrocycles 6e–g and 8e–g almost exclusively with yields equal or greater than 90% (see
SI).
We further tested this approach by probing the lower and upper limits of the scan with
peptides 1–5 and 9–14. The upper limit of our macrocyclic scan was tested with peptides 9–
14, which were subjected to linkers La-Lg (Figure 4). The reaction with linker La produced
the desired cyclic peptide 14a in only 40%, while the oxidized by-product was observed to
be the major species for this reaction (ca. 50%). On the other hand, when linker Lb was used
with peptide 14, the macrocyclic species 14b formed in nearly quantitative yield (Figure 4).
Importantly, reactions with linkers Lc, Le and Lf also produced yields greater than 90% for
the desired peptide macrocycles, whereas reduced yields were observed for Ld and Lg. The
observed reactivity trends suggest that a proper combination of linker length and
electrophilicity are necessary for efficient macrocyclization for longer peptides.
Interestingly, only small amounts of cross-linked macrocyclic species were observed when
Lb was reacted with peptides 1 and 2, where instead large quantities of by-products were
observed (see SI). Observed diminished yields of 1b and 2b are likely due to the
conformational rigidity and length of Lb, which is incompatible with the relatively short
distance separating the Cys residues in peptides 1 and 2. On the other hand, reactions with
other linkers produced corresponding macrocyclic peptides in yields greater than 75% (see
SI). All transformations involving the new family of flexible linkers Ld-Lg produced peptide
macrocyclic products with most yields consistently greater than 90% (see SI and Figure 5).
Upon further investigation, we discovered that macrocyclic peptides 1b and 2b could be
obtained in better yields, when re-optimized conditions featuring higher dilution and lower
stoichiometric ratio of the organic linker are employed (Figure 5). Given previously
recognized difficulties associated with macrocyclization strategies of short peptide
sequences (<4 residues) reported by Fasan and co-workers using bifunctional cross-
linkers,6a this approach demonstrates how this chemistry can circumvent previous
limitations. Similarly, i, i + 4 peptide 4 and its nearest peptide scan neighbors 3 and 5
underwent smooth macrocyclization yielding the desired hybrid macrocyclic species as
major products in yields greater than 80% with new linkers Ld-Lg (see SI and Figure 5),
whereas diminished yields were observed in the formation of 3b and 3c (20% and 41%).
Employing the re-optimized reaction conditions allowed us to improve the respective yields
of peptides 3b and 3c (vide supra). Overall these results highlight the feasibility of the
macrocyclization scan, ultimately demonstrating that properly designed perfluroaromatic-
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based linkers can mediate this process generally irrespective of their chemical identity. The
observed utility of the perfluoroaryl-based SNAr approach for macrocyclization at cysteine
residues significantly expands access to these hybrid structures when compared to the
chemistry featuring allyl and benzyl halides, where yields were found to be extremely
sensitive to the linker.4e
Overall, utilizing only 7 model linkers we produced 98 macrocyclic peptides without
optimization of the conditions for each reaction (Figure 5). In all but one instance we
observed at least a 30% yield of the desired peptide macrocycle, and for reactions employing
next-generation linkers Lc-Lg the yields were greater than 60% (Figure 5). Approximately
half of all the macrocyclization reactions tested, product yields were greater than 90%, and
for the most of the reactions conducted with the new linkers Lc-Lg yields were greater than
80%. To the best of our knowledge, the cysteine perfluoroarylation platform represents the
first instance where a macrocyclization scan can be carried out in a manner generally
independent of the positions of the side-chain amino-acid residues.
To further highlight the generality of the developed macrocyclization platform we
envisioned that it should be possible to avoid the requirement for the linker syntheses by
utilizing a reverse strategy. Specifically, we envisioned incorporating pentafluorophenyl or
nonafluorobiphenyl moieties directly onto unprotected cysteine-containing peptides, which
then can undergo macrocyclization with commercially available dithiol reagents (Figure 2e,
strategy II). To test this hypothesis, we utilized peptide 7, which was treated with excess of
hexafluorobenzene and decafluorobiphenyl reagents yielding bis-perfluoroarylated cysteine
peptides 7a′ and 7b′, respectively. 1,4-Butanedithiol and 1,4-benzenedimethanethiol were
chosen as model dithiol reagents to test for the desired macrocyclization chemistry with 7a′
and 7b′ (Figure 6).
As a standard protocol, 1 mM solutions containing perfluoroaryl-containing peptides 7a′ and
7b′ were treated with 2-fold excess of dithiol linker in the presence of 50 mM solution of
TRIS base in DMF. LC-MS analysis of the reactions indicated complete consumption of the
starting materials occurred within 2 hours and cyclic products were formed with yields
greater than 90% in both cases (Figure 6). These experiments show the reverse strategy for
macrocyclization is indeed feasible. Given that perfluorinated moieties in 7a′ and 7b′ are
less sterically hindered than similar cysteine thiolate sites, more rapid and selective
macrocyclization chemistry is observed as a result. Importantly, long peptide sequences can
undergo efficient macrocyclization via this strategy, as suggested by the nearly quantitative
conversion of peptide 14a′ to its corresponding macrocycle when treated with 1,4-
butanedithiol (see SI).
Conclusions
In summary, for the first time, we show how cysteine perfluoroarylation via SNAr
transformation enables a site-independent and convergent diversity-oriented peptide
macrocyclization scan. Two complementary strategies allow for the rapid construction of
side-chain functionalized peptide macrocycles and simultaneous complexity generation
enabled by the highly tailorable perfluoroaryl-based linkers. Studies performed with model
compounds suggest that the peptide amino-acid sequence and linker identity do not
significantly diminish ones ability to form hybrid macrocycles. Given the recently observed
improvements in stability, cell-uptake and target binding affinity of the peptide macrocycles
stapled with perfluoroaromatic-based moieties, we envision this newly developed scan will
expand the toolbox needed for the development of biologically active constrained-peptide
therapeutics by allowing one to rationally design and screen for promising protein-binding
agents.
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Figure 1.
Convergent diversity-oriented synthetic (DOS) platform for a peptide macrocyclization scan
utilizing a library of chemically tailorable bifunctional linkers. AAx refers to a specific
amino acid residue in the peptide chain sequence.
Zou et al. Page 8
Org Biomol Chem. Author manuscript; available in PMC 2015 January 28.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2.
An unprotected peptide macrocyclization scan enabled by SNAr transformation between
thiols and activated perfluoroaromatics: (a) the reaction scheme highlighting the
regioselectivity of the SNAr process leading to preferential substitution at para position of
the pentafluoroaryl moiety with respect to the R substituent; (b) the reactivity trend of
perfluoroaryl-based electrophiles governed by two independent activation modes; (c) the
library of bifunctional perfluoroaryl-based linkers containing thioether moieties capable of
activating corresponding para-CF moiety towards nucleophilic attack via resonance
stabilization of the Meisenheimer intermediate; (d) two independent strategies designed to
probe macrocyclization scan with linkers La-Lg; and (e) 14 model cysteine-containing
unprotected peptides used for the studies.
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Figure 3.
LC-MS chromatograms (total ion current) of purified peptide 7 and corresponding
macrocyclization reactions with linkers La-Lg analyzed in situ. Peaks labeled as * represent
oxidized disulfide by-product.
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Figure 4.
LC-MS chromatograms (total ion current) of purified peptide 14 and corresponding
macrocyclization reactions with linkers La-Lg analyzed in situ. Peaks labeled as * represent
oxidized disulfide by-product.
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Figure 5.
Bar graph summary of the macrocyclization scan with peptides 1–14 and linkers La-Lg.
Number within each bar represents corresponding yield of the macrocyclization product
determined by LC-MS analysis of the unpurified product mixture. Note, for yields denoted
with *, re-optimized conditions were employed (see SI).
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Figure 6.
Synthesis of cysteine perfluorinated peptides 7a′ and 7b′, LC-MS chromatograms (total ion
current) of purified peptides 7a′ and 7b′, and corresponding macrocyclization reactions with
dithiol linkers (highlighted in grey) analyzed in situ.
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